Nasdaq-100 (US100) as well as other Wall Street indices have been struggling recently. Still-tense geopolitical situation in the Middle East, as well as declining market odds for the beginning of Fed rate cut cycle in the first half of this year, are putting pressure on US equity markets. Big tech companies, which were drivers of Wall Street gains in 2023 and Q1 2024 also saw their rallies ease or halt.
However, things may be about to change. We are entering a period of Wall Street earnings season, that will see release of Q1 report from US big tech companies. This is a chance for Nasdaq-100 especially. Among key Nasdaq-100 members that will report earnings this week, one can find:
Start investing today or test a free demo
Open real account TRY DEMO Download mobile app Download mobile app- Tesla (TSLA.US) - Tuesday, after market close
- Meta Platforms (META.US) - Wednesday, after market close
- Alphabet (GOOGL.US) - Thursday, after market close
- Intel (INTC.US) - Thursday, after market close
- Microsoft (MSFT.US) - Thursday, after market close
Taking a look at US100 chart at H4 interval, we can see that the index is trading around 7% below all-time highs reached at the end of March 2024. Index have been pulling back since the beginning of Q2 2024, but the downward move has been halted recently at the 61.8% retracement of the upward move launched at the beginning of January 2024. However, attempts to launch a recovery move were halted in the 17,450 pts area. Strong reports from US big tech companies may help fuel a longer-lasting recovery. On the other hand, failure to appease investors and show Q1 results that matched Q1 stock performance may trigger another leg lower in the ongoing pullback. In case the index breaks below 17,250 pts support, the next potential support can be found in the 17,000 pts area.
Source: xStation5
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
